BGI Opens Seattle Office for North America Expansion

Global Genomics Leader Builds Health Partnerships  SEATTLE -- BGI, a leading global genomics organization headquartered inShenzhen, announced it is expanding its international operations with the formation of a new division, BGI Groups USA, to be based in Seattle. BGI is engaged in scientific research, genomic sequencing, precision medicine, agriculture, bioinformatics and related technologies with a vision [...]

Takara Bio USA Holdings, Inc. and Rubicon Genomics Announce Merger Agreement

Mountain View, CA and Ann Arbor, MI—Takara Bio USA Holdings, Inc. (“TBUSH”) and Rubicon Genomics, Inc. (“Rubicon”), today announced the signing of a merger agreement pursuant to which TBUSH will acquire Rubicon, a privately-owned company headquartered in Ann Arbor, Michigan. Rubicon is a leading provider of pre-analytical library preparation kits that increase the accuracy, efficiency [...]

PathSensors Launches Low Cost, High Speed Anthrax and Bio Threat Detection Solution for Mail Security Screening

Bioflash MailGuard Detects Anthrax, Ricin and Other Bio Threats in Mail and Suspicious Powders At Fraction of Cost of Alternative Solutions Baltimore, Maryland Baltimore bio tech firm, PathSensors, Inc., announced today the launch of its new Bioflash MailGuardtm mail security screening solution. The Bioflash MailGuardtm system provides a fast, highly accurate, easy to use and [...]

Gyros Protein Technologies and Abacus ALS Sign Distribution Agreement

Uppsala, Sweden: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today that it has appointed Abacus ALS as exclusive distributor of its immunoassay products in Australia and New Zealand. Abacus ALS, an ISO 9001: 2008 accredited organization, is one of Australia’s and New Zealand’s [...]

PacBio Announces Termination of Agreement with Roche Diagnostics

MENLO PARK, Calif. -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), today announced that F. Hoffman-La Roche Ltd(Roche) has elected to terminate for convenience the development, commercialization and license agreement with Pacific Biosciences for the development and supply of diagnostic products based on the company's Single Molecule, Real-Time (SMRT®) technology. The agreement, which was entered into by [...]

Roche announces termination of 2013 Development, Commercialization and License Agreement with Pacific Biosciences

PLEASANTON, Calif. -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has officially notified Pacific Bioscience (PacBio) of its intention to terminate its agreement and efforts to develop a sequencing instrument for use in the clinical research and clinical market using their Single Molecule, Real-Time (SMRT®) technology. With this termination, Roche no longer retains rights [...]

Dr. Stefan Traeger will be the new Chairman of the Executive Board of JENOPTIK AG

In its meeting today, the Supervisory Board of JENOPTIK AG has appointed Dr. Stefan Traeger as the future Chairman of the company’s Executive Board for a term of three years. Dr. Stefan Traeger (49), at present member of the Management Board of the Swiss Tecan Group AG, will succeed Dr. Michael Mertin, who will not [...]

Fujifilm to Acquire Wako Pure Chemical Industries from Takeda Pharmaceutical by Tender Offer

FUJIFILM Corporation (President & COO: Kenji Sukeno) (“Fujifilm”) is pleased to announce that it approved the acquisition of a leading reagent manufacturer Wako Pure Chemical Industries, Ltd. (President: Shinzo Kobatake) (“Wako”) at today's Board of Directors Meeting. Fujifilm signed an agreement with Takeda Pharmaceutical Company Limited (President & CEO: Christophe Weber) (“Takeda”) whereby the Takeda [...]

Univercells Receives $12 Million Grant to Develop Breakthrough Vaccine Manufacturing Platform

Univercells and consortium partners Batavia Biosciences and Natrix Separations selected by Bill & Melinda Gates Foundation to Radically Reduce Vaccine Costs for Developing Countries Brussels, Belgium – Univercells announced today that it has been awarded a $12 million grant by the Bill & Melinda Gates Foundation for the development of a breakthrough vaccine manufacturing platform [...]

Repligen Acquires TangenX Technology Corporation

Adds innovative single-use SiusTM TFF technology to downstream bioprocessing portfolio WALTHAM, MA – Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has acquired TangenX Technology Corporation (“TangenX”) of Shrewsbury, MA, maker of the innovative single-use SiusTM line of tangential flow filtration (“TFF”) cassettes and hardware used in downstream biopharmaceutical manufacturing [...]

Access IBO on Knowledge Center